tofacitinib (xeljanz) Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB
Back

Drug Pricing Summary

AUS PBS

$16.6705

VA Big4

$51.7758 - $116.7267

VA FSS

$52.6707 - $138.6363

NADAC

$79.9759 - $159.8195

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
tofacitinib citrate 10 mg (TABLET) $51.7758 VA Big4
  • XELJANZ (60)
    		•  Pfizer, Inc.
    tofacitinib citrate 10 mg (TABLET) $52.6707 VA FSS
  • XELJANZ (60)
    		•  Pfizer, Inc.
    tofacitinib citrate 11 mg (TABLET) $109.7200 VA Big4
  • XELJANZ (30)
    		•  Pfizer, Inc.
    tofacitinib citrate 11 mg (TABLET) $138.6363 VA FSS
  • XELJANZ (30)
    		•  Pfizer, Inc.
    tofacitinib citrate 11 mg (TABLET) $159.8195 NADAC brand
  • XELJANZ (1)
    		•  Pfizer Laboratories Div Pfizer Inc
    tofacitinib citrate 22 mg (TABLET) $116.7267 VA Big4
  • XELJANZ (30)
    		•  Pfizer, Inc.
    tofacitinib citrate 22 mg (TABLET) $118.0950 VA FSS
  • XELJANZ (30)
    		•  Pfizer, Inc.
    tofacitinib citrate 5 mg (TABLET) $16.6705 AUS PBS generic
  • Xeljanz (56)
    		•  Pfizer Australia Pty Ltd
    tofacitinib citrate 5 mg (TABLET) $54.9985 VA Big4
  • XELJANZ (60)
    		•  Pfizer, Inc.
    tofacitinib citrate 5 mg (TABLET) $61.7708 VA FSS
  • XELJANZ (60)
    		•  Pfizer, Inc.
    tofacitinib citrate 5 mg (TABLET) $79.9759 NADAC brand
  • XELJANZ (1)
    		•  Pfizer Laboratories Div Pfizer Inc

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue